Targeted Biological Therapies for Graves’ Disease and Thyroid-Associated Ophthalmopathy. Focus on B-Cell Depletion With Rituximab
Clinical Endocrinology - United Kingdom
doi 10.1111/j.1365-2265.2010.03806.x
Full Text
Open PDFAbstract
Available in full text
Date
December 15, 2010
Authors
Publisher
Wiley